Incidence of multidrug resistant Pseudomonas aeruginosa isolated from burn patients and environment of teaching institution

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 5, 2014, Pages 26-29

  Biswal, Indu ^a   Arora, Balvinder Singh ^b   Kasana, Dimple ^b   Neetushree, ^c  

^a Delhi State Cancer Institute   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c Department of Microbiology Hindu Rao Medical College and Hospital   (India)

Author keywords

Antibiotyping; Multidrug resistance; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BURN PATIENT; DISK DIFFUSION; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS INFECTION;

EID: 84901287426     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/7483.4383     Document Type: Article

References (19)

1. Carmeli YN, Troillet G, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 1999; 3:1379-82.
2. Vahdani M, Azimi L, Asghari B, Bazmi F, Rastegar LA. Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns. Ann Burns Fire Disasters. 2012;25(2):78-81.
3. Scaife W, Young HK, Paton RH, Amyes SG. Transferable imipenem resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother. 1995; 36: 585-6.
4. Magiorakos AP. Multidrug Resistant (MDR), Extensively Drug Resistant (XDR) and Pandrug-1 Resistant (PDR) bacteria in healthcare settings. Expert Proposal for a Standardized International Terminology, 2011. Available online at www.escmid.org.
5. Collee JG, Fraser AG, Marmion BP, Simmons A. Mackie and McCartney Practical Medical Microbiology. 14th ed. Edinburgh: Churchill Livingstone; 1996.
6. Clinical and Laboratory Standards Institute (CLSI).2011.Performance standards for antimicrobial susceptibility testing; Twenty first Informational supplement. M100-S21. Wayne, PA: CLSI; 2011.
7. Srinivasan S, Vartak AM, Patil A, Saldanha J. Bacteriology of burn wound at the Baba Jerbai Wadia hospital for children, Mumbai- A 13 year study. Indian J Plastic Surg. 2009; 42(2):213-8.
8. Saha SK, Muazzam N, Begum SA, Chowdhury A, Islam MS, Parveen R. Study on time-related changes in aerobic bacterial pattern of burn wound infection. Faridpur Med Coll J. 2011; 6 (1):41-5.
9. Kaushik R, Kumar S, Sharma R, Lal P. Bacteriology of burn wounds - the first three years in a new burn unit at the medical College, Chandigarh. Burns. 2001; 27: 595-7.
10. Singh NP, Goyal V, Manchanda V, Das S, Kaur I, Talwar V. Changing trends in bacteriology of burns in the burns unit, Delhi, India. Burns. 2003; 29: 129-32.
11. Taneja N, Emmanuel R, Chari PS, Sharma M. A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India. Burns. 2004; 30: 665-9.
12. Agnihotri N, Gupta V, Joshi RM. Aerobic bacterial isolates from burn wound infections and their antibiograms-a five-year study. Burns. 2004; 30: 241-3.
13. Ganesamoni S, Kate V, Sadasivan J. Epidemiology of hospitalized burn patients in a tertiary care hospital in South India. Burns. 2010; 36: 422-9.
14. Unan D, Gnseren F. The resistance of P. aeruginosa strains isolated from nosocomial infections against various antibiotics. Mikrobiyol Bult. 2000; 34: 255-60.
15. Sabir R, Alvi SFD, Fawwad A. Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi- Pakistan. Pak J Med Sci. 2013; 29(3): 851-5.
16. Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa Isolated from Clinical and Environmental Samples in Minia, Egypt: Prevalence, Antibiogram and Resistance Mechanisms. J Antimicr Chemother. 2007; 60: 1010-7.
17. Ramprasad BP, Marissa R, Suprama D. Role of Pseudomonas in Nosocomial Infections and Biological Characterization of Local Strains. J Biosci Tech. 2010; l1(4): 170-9.
18. Pfaller MA, Jones RN. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated worldwide. Diagn Microbiol Infect Dis. 1997; 28:157-63
19. Pfaller MA, Jones RN, Biedenbach DJ, the MYSTIC Program Study Group (USA). Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA). Diagn Microbiol Infect Dis. 2001; 41:177-82